ConductScience.org, home

Paper17237828

Marrow transplantation for severe aplastic anemia with significant renal impairment.

Gerrie A and 4 others. Bone Marrow Transplant, 2007. Cited by 10 papers, by iCite.

Cite this record

ConductScience Library. Marrow transplantation for severe aplastic anemia with significant renal impairment. Papers, record 17237828. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17237828

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Marrow transplantation for severe aplastic anemia with significant renal impairment.
PubMed
Journal
Bone Marrow Transplant
PubMed
Year
2007
PubMed
Publication types
Case Reports, Letter
PubMed
Citations, by iCite
10
iCite
Relative citation ratio, by iCite
0.3
iCite
Revised in PubMed
2026-10-10
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Gerrie AA
2Marsh JJ
3Lipton JHJ H
4Messner HH
5Gupta VV

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Anemia, AplasticMajor topic
Bone Marrow TransplantationMajor topic
Renal InsufficiencyMajor topic
Transplantation ConditioningMajor topic
Adult
Female
Humans
Male
Middle Aged
Remission Induction
Transplantation, Homologous

Source PubMed

Download CSV of topics

References10

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
111215697Cyclophosphamide and antithymocyte globulin to condition patients with aplastic anemia for allogeneic marrow transplantations: the experience in four centers.Biol Blood Marrow Transplant2001https://conductscience.org/library/papers/11215697PubMed
212189539Successful allogeneic blood stem cell transplantation for aplastic anemia in a patient with renal insufficiency requiring dialysis.Bone Marrow Transplant2002https://conductscience.org/library/papers/12189539PubMed
311041571Myopericarditis caused by cyclophosphamide used to mobilize peripheral blood stem cells in a myeloma patient with renal failure.Bone Marrow Transplant2000https://conductscience.org/library/papers/11041571PubMed
411918757Cyclophosphamide pharmacokinetics and dose requirements in patients with renal insufficiency.Kidney Int2002https://conductscience.org/library/papers/11918757PubMed
514586713Roles of bone marrow cells in glomerular diseases.Clin Exp Nephrol2003https://conductscience.org/library/papers/14586713PubMed
615665848Marrow transplants from matched unrelated donors for aplastic anaemia using alemtuzumab, fludarabine and cyclophosphamide based conditioning.Bone Marrow Transplant2005https://conductscience.org/library/papers/15665848PubMed
79383228High-dose chemotherapy and autologous peripheral blood stem cell transplantation in patients with multiple myeloma and renal insufficiency.Bone Marrow Transplant1997https://conductscience.org/library/papers/9383228PubMed
812451240Induction of kidney allograft tolerance after transient lymphohematopoietic chimerism in patients with multiple myeloma and end-stage renal disease.Transplantation2002https://conductscience.org/library/papers/12451240PubMed
916433761Chronic kidney disease following non-myeloablative hematopoietic cell transplantation.Am J Transplant2006https://conductscience.org/library/papers/16433761PubMed
1010571789Bone marrow transplantation attenuates murine IgA nephropathy: role of a stem cell disorder.Kidney Int1999https://conductscience.org/library/papers/10571789PubMed

Download CSV of references

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 10 citations.

PMIDTitleJournalYearIn PapersSource
19597429Successful allo-SCT in a Fanconi anemia patient with renal impairment using reduced doses of CY and fludarabine.Bone Marrow Transplant2010https://conductscience.org/library/papers/19597429PubMed
18372907Graft-versus-host disease following marrow transplantation for aplastic anemia: different impact of two GVHD prevention strategies.Bone Marrow Transplant2008https://conductscience.org/library/papers/18372907PubMed
18332906Successful bone marrow transplantation in a girl with Fanconi anemia and preterminal renal failure.Bone Marrow Transplant2008https://conductscience.org/library/papers/18332906PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/17237828

GET https://conductscience.org/api/papers/v1/17237828/authors